Investing.com -- ​​The latest round of tariffs announced by the US administration is expected to weigh heavily on economic growth in the eurozone and the UK, increasing the likelihood of a recession ...

Read More »

Barclays sees upside potential in Sandoz shares are tariffs risk is priced in

Regarding tariffs, Barclays estimates the financial impact of existing and potential duties on Sandoz at $25-$35 million in 2025, with an annualized impact of $35-$50 million. If the European Union ...

Read More »

FTSE 100 and Wall Street higher as Trump tariff clock ticks down

Yesterday, stocks across Europe fell as companies brace for an uncertain future under the administration's 'reciprocal' tariffs policy.

Read More »

Barclays cuts Novo Nordisk estimates on lower Wegovy, Ozempic volumes in the U.S.

Barclays (LON:BARC) has lowered its first-quarter 2025 estimates for Novo Nordisk (CSE:NOVOb) (NYSE:NVO) ahead of its Q1 2025 report, citing weaker-than-expected prescription volumes for key drugs ...

Read More »

Barclays upgrades Bunzl, citing stronger FY25 outlook and M&A potential

Barclays projects a positive earnings outlook for Bunzl, with approximately 6% annual growth expected for FY25-27, including buybacks, and potential for M&A to further supplement this growth. This is ...

Read More »